hCD3EDG/hBCMA
品系全名
C57BL/6JSmo-Tnfrsf17tm1(hBCMA)Cd3etm1(hCD3E)Cd3dtm1(hCD3D)Cd3gtm1(hCD3G)Smoc
目录号
NM-XA-253164
品系状态
活体
品系描述
通过hBCMA(NM-HU-200228)与hCD3EDG(NM-HU-220120)小鼠交配获得。
验证数据

Fig.1 Detection of hBCMA expression on TACI+CD138+ cells in spleen and bone marrow of WT C57BL/6 mice and HO hCD3EDG/hBCMA mice by FACS. hBCMA was exclusively detectable in hCD3EDG/hBCMA humanized mice but not in wild-type mice. hBCMA was exclusively detectable on TACI+CD138+ cells in hBCMA humanized mice. Leukocytes were collected from wild-type C57BL/6 mice (female, 8 weeks old) and homozygous hCD3EDG/hBCMA humanized mice (female, 12 weeks old), and analyzed by flow cytometry with anti-hBCMA.
Abbr. HO, homozygous; WT, wild type.

Fig 2. In vivo efficacy study of teclistamab in HO hCD3EDG/hBCMA mice.
Teclistamab were injected at day 0, 3, 5, and immune cells in the spleen and bone marrow of mice after therapy were measured by flow cytometry (n=2). Values are shown as mean ± SEM.
你也可能感兴趣
Tamoxifen诱导Cre-ERT2小鼠 使用指南
Cre-ERT2在无Tamoxifen诱导的情况下,在细胞质内处于无活性状态;当Tamoxifen诱导后,Tamoxifen的代谢产物4-OHT(雌激素类似物)与ERT结合,可使Cre-ERT2进核发挥Cre重组酶活性。
查看Cre-lox系统介绍及使用汇总
你一定听说过Cre-lox重组系统,无论你是否直接进行过基因操作。由于Cre-lox系统具有操作简单、重组率高的优点,如今已经成为体内外遗传操作的强有力工具。利用Cre-lox系统,可以在特定细胞、组织或整个生物体,甚至在特定时间点敲除或表达某个基因,实现对特定基因的时空特异性操作,这对基因功能的研究和人类疾病动物模型的建立都具有深刻影响。
查看
